$NTVA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEXIEN BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEXIEN BIOPHARMA, INC.. Get notifications about new insider transactions in NEXIEN BIOPHARMA, INC. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | NTVA | NEXIEN BIOPHARMA, ... | Wasoff Evan L | Chief Financial Off ... | Grant | A | 0.00 | 1,000,000 | 0 | 2,000,000 | 1000 K to 2 M (+100.00 %) |
| Apr 05 2021 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Grant | A | 0.00 | 1,000,000 | 0 | 3,685,192 | 2.7 M to 3.7 M (+37.24 %) |
| Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.05 | 1,062,953 | 48,045 | 1,062,953 | |
| Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.04 | 1,062,953 | 46,026 | 1,062,953 | |
| Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.04 | 1,062,953 | 42,837 | 1,062,953 | |
| Aug 21 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.08 | 2,500,000 | 200,000 | 2,500,000 | |
| Aug 21 2020 | NTVA | NEXIEN BIOPHARMA, ... | Wasoff Evan L | Chief Financial Off ... | Option Exercise | A | 0.08 | 1,500,000 | 120,000 | 1,500,000 | |
| Aug 21 2020 | NTVA | NEXIEN BIOPHARMA, ... | Goldfarb Robert I | Chief Operating Off ... | Option Exercise | A | 0.08 | 1,000,000 | 80,000 | 1,000,000 | |
| Aug 14 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Buy | C | 0.01 | 1,800,880 | 25,212 | 2,688,880 | 888 K to 2.7 M (+202.80 %) |
| Nov 25 2019 | NTVA | NEXIEN BIOPHARMA, ... | Friedland Jeffrey | Gift | G | 0.00 | 228,800 | 0 | 0 | 228.8 K to 0 (-100.00 %) | |
| Nov 25 2019 | NTVA | NEXIEN BIOPHARMA, ... | Friedland Jeffrey | Gift | G | 0.00 | 833,333 | 0 | 0 | 833.3 K to 0 (-100.00 %) | |
| May 02 2019 | NTVA | NEXIEN BIOPHARMA, ... | Kanativa Inc. | 10% Owner | Sell | S | 0.09 | 5,000,000 | 425,000 | 19,000,000 | 24 M to 19 M (-20.83 %) |
| May 01 2019 | NTVA | NEXIEN BIOPHARMA, ... | Kanativa USA Inc. | 10% Owner | Sell | S | 0.09 | 5,000,000 | 425,000 | 19,000,000 | 24 M to 19 M (-20.83 %) |
| May 01 2019 | NTVA | NEXIEN BIOPHARMA, ... | Friedland Jeffrey | Sell | S | 0.09 | 5,000,000 | 425,000 | 19,000,000 | 24 M to 19 M (-20.83 %) | |
| Oct 30 2018 | NTVA | NEXIEN BIOPHARMA, ... | Wasoff Evan L | Chief Financial Off ... | Option Exercise | A | 0.66 | 200,000 | 131,000 | 200,000 | |
| Oct 29 2018 | NTVA | NEXIEN BIOPHARMA, ... | Bankier Alain D | Executive Chairman | Option Exercise | A | 0.66 | 500,000 | 327,500 | 500,000 | |
| Oct 29 2018 | NTVA | NEXIEN BIOPHARMA, ... | Bankier Alain D | Executive Chairman | Option Exercise | A | 0.48 | 500,000 | 240,000 | 500,000 | |
| Oct 29 2018 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | EVP | Option Exercise | A | 0.66 | 100,000 | 65,500 | 100,000 | |
| Sep 05 2018 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Chief Executive Off ... | Option Exercise | J | 1.00 | 28,000 | 28,000 | 28,000 | |
| Sep 05 2018 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Chief Executive Off ... | Option Exercise | J | 0.50 | 28,000 | 14,000 | 0 | |
| Sep 04 2018 | KDRH | Intiva BioPharma I ... | Snider Lindy | Option Exercise | J | 1.00 | 40,000 | 40,000 | 40,000 | ||
| Sep 04 2018 | KDRH | Intiva BioPharma I ... | Snider Lindy | Option Exercise | J | 0.50 | 40,000 | 20,000 | 0 | ||
| Sep 04 2018 | KDRH | Intiva BioPharma I ... | Goldfarb Robert I | Chief Operating Off ... | Option Exercise | J | 1.00 | 2,400 | 2,400 | 2,400 | |
| Sep 04 2018 | KDRH | Intiva BioPharma I ... | Goldfarb Robert I | Chief Operating Off ... | Option Exercise | J | 0.50 | 2,400 | 1,200 | 0 | |
| Jul 27 2018 | KDRH | Intiva BioPharma I ... | Snider Lindy | Option Exercise | A | 0.54 | 100,000 | 54,000 | 100,000 | ||
| Jul 26 2018 | KDRH | Intiva BioPharma I ... | Wasoff Evan L | Chief Financial Off ... | Option Exercise | A | 0.54 | 420,000 | 226,800 | 420,000 | |
| Jul 26 2018 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Chief Executive Off ... | Option Exercise | A | 0.54 | 100,000 | 54,000 | 100,000 | |
| Jul 26 2018 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Chief Executive Off ... | Option Exercise | A | 0.54 | 840,000 | 453,600 | 840,000 | |
| Jul 26 2018 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Option Exercise | A | 0.54 | 150,000 | 81,000 | 150,000 | |
| Jun 29 2018 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Option Exercise | X | 0.38 | 88,000 | 33,440 | 0 | |
| Jun 29 2018 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Option Exercise | J | 0.38 | 88,000 | 33,440 | 88,000 | |
| Jun 29 2018 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Buy | X | 0.38 | 88,000 | 33,440 | 888,000 | 800 K to 888 K (+11.00 %) |
| Jun 29 2018 | KDRH | Intiva BioPharma I ... | Snider Lindy | Option Exercise | X | 0.38 | 40,000 | 15,200 | 0 | ||
| Jun 29 2018 | KDRH | Intiva BioPharma I ... | Snider Lindy | Buy | X | 0.38 | 40,000 | 15,200 | 480,000 | 440 K to 480 K (+9.09 %) | |
| May 23 2018 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Chief Executive Off ... | Option Exercise | X | 0.38 | 28,000 | 10,640 | 0 | |
| May 23 2018 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Chief Executive Off ... | Buy | X | 0.38 | 28,000 | 10,640 | 2,256,000 | 2.2 M to 2.3 M (+1.26 %) |
| May 22 2018 | KDRH | Intiva BioPharma I ... | Goldfarb Robert I | Chief Operating Off ... | Option Exercise | X | 0.38 | 2,400 | 912 | 0 | |
| May 22 2018 | KDRH | Intiva BioPharma I ... | Goldfarb Robert I | Chief Operating Off ... | Buy | X | 0.38 | 2,400 | 912 | 1,028,800 | 1 M to 1 M (+0.23 %) |
| Mar 12 2018 | KDRH | Intiva BioPharma I ... | Friedland Jeffrey | Sell | D | 0.00 | 1,166,667 | 0 | 833,333 | 2 M to 833.3 K (-58.33 %) | |
| Feb 26 2018 | KDRH | Intiva BioPharma I ... | Goldfarb Robert I | Chief Operating Off ... | Option Exercise | X | 0.25 | 2,400 | 600 | 0 | |
| Feb 26 2018 | KDRH | Intiva BioPharma I ... | Goldfarb Robert I | Chief Operating Off ... | Buy | L | 0.25 | 2,400 | 600 | 1,026,400 | 1 M to 1 M (+0.23 %) |
| Feb 26 2018 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Option Exercise | X | 0.25 | 28,000 | 7,000 | 0 | ||
| Feb 26 2018 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Buy | L | 0.25 | 28,000 | 7,000 | 2,228,000 | 2.2 M to 2.2 M (+1.27 %) | |
| Feb 23 2018 | KDRH | Intiva BioPharma I ... | Friedland Jeffrey | Chief Executive Off ... | Option Exercise | X | 0.25 | 20,800 | 5,200 | 0 | |
| Feb 23 2018 | KDRH | Intiva BioPharma I ... | Friedland Jeffrey | Chief Executive Off ... | Buy | L | 0.25 | 20,800 | 5,200 | 228,800 | 208 K to 228.8 K (+10.00 %) |
| Dec 01 2017 | KDRH | Intiva BioPharma I ... | Goldfarb Robert I | Chief Operating Off ... | Option Exercise | J | 0.50 | 2,400 | 1,200 | 2,400 | |
| Dec 01 2017 | KDRH | Intiva BioPharma I ... | Goldfarb Robert I | Chief Operating Off ... | Option Exercise | J | 0.38 | 2,400 | 900 | 2,400 | |
| Dec 01 2017 | KDRH | Intiva BioPharma I ... | Goldfarb Robert I | Chief Operating Off ... | Option Exercise | J | 0.25 | 2,400 | 600 | 2,400 | |
| Dec 01 2017 | KDRH | Intiva BioPharma I ... | Goldfarb Robert I | Chief Operating Off ... | Buy | J | 0.00 | 644,227 | 0 | 1,024,000 | 379.8 K to 1 M (+169.63 %) |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Buy | J | 0.00 | 503,303 | 0 | 800,000 | 296.7 K to 800 K (+169.64 %) |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Buy | J | 0.00 | 15,099,083 | 0 | 24,000,000 | 8.9 M to 24 M (+169.64 %) |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Intiva USA Inc | Buy | J | 0.00 | 15,099,083 | 0 | 24,000,000 | 8.9 M to 24 M (+169.64 %) | |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Friedland Jeffrey | Chief Executive Off ... | Option Exercise | J | 0.50 | 20,800 | 10,400 | 20,800 | |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Friedland Jeffrey | Chief Executive Off ... | Option Exercise | J | 0.38 | 20,800 | 7,800 | 20,800 | |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Friedland Jeffrey | Chief Executive Off ... | Option Exercise | J | 0.25 | 20,800 | 5,200 | 20,800 | |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Friedland Jeffrey | Chief Executive Off ... | Buy | J | 0.00 | 130,859 | 0 | 208,000 | 77.1 K to 208 K (+169.64 %) |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Friedland Jeffrey | Chief Executive Off ... | Buy | J | 0.00 | 1,258,257 | 0 | 2,000,000 | 741.7 K to 2 M (+169.64 %) |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Friedland Jeffrey | Chief Executive Off ... | Buy | J | 0.00 | 15,099,083 | 0 | 24,000,000 | 8.9 M to 24 M (+169.64 %) |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Option Exercise | J | 0.50 | 28,000 | 14,000 | 28,000 | ||
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Option Exercise | J | 0.38 | 28,000 | 10,500 | 28,000 | ||
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Option Exercise | J | 0.25 | 28,000 | 7,000 | 28,000 | ||
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Bankier Alain D | Buy | J | 0.00 | 1,384,083 | 0 | 2,200,000 | 815.9 K to 2.2 M (+169.64 %) | |
| Nov 30 2017 | KDRH | Intiva BioPharma I ... | Wasoff Evan L | Chief Financial Off ... | Buy | J | 0.00 | 629,128 | 0 | 1,000,000 | 370.9 K to 1000 K (+169.63 %) |
| Oct 18 2017 | KDRH | Kinder Holding Cor ... | Greenberg Richard S | EVP and Chairman | Buy | J | 0.00 | 1,780,183 | 0 | 1,780,183 | 0 to 1.8 M |
| Oct 18 2017 | KDRH | Kinder Holding Cor ... | Greenberg Richard S | EVP and Chairman | Buy | J | 0.00 | 53,405,501 | 0 | 53,405,501 | 0 to 53.4 M |
| Oct 18 2017 | KDRH | Kinder Holding Cor ... | Greenberg Richard S | EVP and Chairman | Sell | J | 0.00 | 20,000,000 | 0 | 0 | 20 M to 0 (-100.00 %) |
| Oct 17 2017 | KDRH | Kinder Holding Cor ... | Friedland Jeffrey | Chief Executive Off ... | Buy | J | 0.00 | 462,848 | 0 | 462,848 | 0 to 462.8 K |
| Oct 17 2017 | KDRH | Kinder Holding Cor ... | Friedland Jeffrey | Chief Executive Off ... | Buy | J | 0.00 | 4,450,458 | 0 | 4,450,458 | 0 to 4.5 M |
| Oct 17 2017 | KDRH | Kinder Holding Cor ... | Friedland Jeffrey | Chief Executive Off ... | Buy | J | 0.00 | 53,405,501 | 0 | 53,405,501 | 0 to 53.4 M |
| Oct 17 2017 | KDRH | Kinder Holding Cor ... | Friedland Jeffrey | Chief Executive Off ... | Sell | J | 0.00 | 20,000,000 | 0 | 0 | 20 M to 0 (-100.00 %) |
| Oct 17 2017 | KDRH | Kinder Holding Cor ... | Intiva USA Inc | Buy | J | 0.00 | 53,405,501 | 0 | 53,405,501 | 0 to 53.4 M | |
| Oct 17 2017 | KDRH | Kinder Holding Cor ... | Intiva USA Inc | Sell | J | 0.00 | 20,000,000 | 0 | 0 | 20 M to 0 (-100.00 %) |
Page: 1